Projeto piloto de implantação de uma cozinha cetogênica para tratamento de epilepsia refratária

Autores

  • Lenycia de Cassya Lopes Neri
  • Rafaela Rodrigues Vieira
  • Sabrina Moura Mercham de Santana
  • Letícia Pereira de Brito Sampaio

Palavras-chave:

Dieta cetogênica, Epilepsia, Educação alimentar e nutricional

Resumo

Objetivo: verificar alterações no consumo alimentar e hábitos de vida em pacientes com fibrose cística brasileiros durante o período de isolamento social devido a pandemia de COVID-19. Métodos: pesquisa transversal com levantamento de dados por meio de questionário elaborado pela equipe de nutricionistas especialistas no tratamento de pacientes com fibrose cística, com questões referentes às manifestações respiratórias recentes de pacientes ou familiares, alterações nos hábitos de aquisição e compras de alimentos e alterações quanto ao consumo de grupos alimentares e suplementos. Os dados foram tabulados e foi realizada uma análise descritiva. Resultados: 40,34% das famílias de pacientes com fibrose cística mudaram os hábitos de compras de alimentos, cerca de 40% dos pacientes diminuíram a prática de atividade física e aumentaram o tempo de uso de telas em mais de 50% durante o período da pandemia de COVID-19. Conclusões: Apesar de algumas dificuldades relacionadas à aquisição dos alimentos e alterações em hábitos de vida, houve manutenção do consumo alimentar da maioria dos grupos alimentares e suplementos pelos pacientes pediátricos com fibrose cística brasileiros durante o isolamento social devido a pandemia de COVID-19.

Referências

Sampaio LPB. Ketogenic diet for epilepsy treatment. Arq. Neuro-Psiquiatr. 2016 [cited 2020 march 3];74(10):842-848. https://doi.org/10.1590/0004-282X20160116

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R. Ketogenic Diet and Epilepsy. Nutrients. 2019 [cited 2020 march 3];11(10):2510. https://doi.org/10.3390/nu11102510

Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020 [cited 2020 august 21];6(6):CD001903. https://doi.org/10.1002/14651858.CD001903.pub5

D'Andrea Meira I, Romão TT, Pires do Prado HJ, Krüger LT, Pires MEP, da Conceição PO. Ketogenic Diet and Epilepsy: What We Know So Far. Front Neurosci. 2019 [cited 2020 march 3];13:5. https://doi.org/10.3389/fnins.2019.00005

Lin KL, Lin JJ, Wang HS. Application of ketogenic diets for pediatric neurocritical care. Biomed J. 2020 [cited 2020 august 21];43(3):218-225. https://doi.org/10.1016/j.bj.2020.02.002

Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008 [cited 2020 march 3];7(6):500-506. https://doi.org/10.1016/S1474-4422(08)70092-9

Garcia-Penas JJ. Epilepsy, cognition and ketogenic diet. Rev Neurol 2018. [cited 2020 march 3];66(Supl.1):S71-S75. https://doi.org/10.33588/rn.66S01.2017529

Wang Y, Fang Z, Zhang Y, Xie L, Jiang L. Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis. Seizure. 2020 [cited 2020 august 21];18(81):36-42. https://doi.org/10.1016/j.seizure.2020.07.011

Gavrilovici C, Rho JM. Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms. J Inherit Metab Dis. 2020 [cited 2020 august 21]. https://doi.org/10.1002/jimd.12283

Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020 [cited 2020 august 21];61(6):1261-1281. https://doi.org/10.1111/epi.16543

Dressler A, Trimmel-Schwahofer P. The ketogenic diet for infants: How long can you go? Epilepsy Res. 2020 [cited 2020 august 21];164:106339. https://doi.org/10.1016/j.eplepsyres.2020.106339

Algahtani F, Imran I, Pervaiz H, Ashraf W, Perveen N, Rasool MF et al. Non-pharmacological Interventions for Intractable Epilepsy. Saudi Pharm J. 2020 [cited 2020 august 21];28(8):951-962). https://doi.org/10.1016/j.jsps.2020.06.016

Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Bergqvist AGC, Blackford R et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 [cited 2020 march 3];3(2)175-192. https://doi.org/10.1002/epi4.12225

Fenton C, Groveman S, Chee CM, Bergqvist AGC. Benefits of a Ketogenic Teaching Kitchen. J. Child Neurol. 2019 [cited 2020 march 3];34(14):886-890. https://doi.org/10.1177/0883073819866607

Matthew's Friends Clinics - Ketogenic Dietary Therapies. Collection of Classical Recipes. 1 ed. Lingfield: Matthew's Friends Ketocook; 2012.

Universidade Estadual de Campinas. Tabela Brasileira de Composição de Alimentos (TACO). 4 ed. Campinas: UNICAMP/NEPA; 2011. [cited 2020 march 3]. Available in: http://www.unicamp.br/nepa/taco/tabela.php?ativo=tabela.

Freitas A, Paz JA, Casella EB, Marques-Dias MJ. Ketogenic diet for the treatment of refractory epilepsy: a 10 year experience in children. Arq Neuropsiquiatr. 2007 [cited 2020 march 31];65(2B):381-4. https://doi.org/10.1590/S0004-282X2007000300003

Katyal NG, Koehler AN, McGhee B, Foley CM, Crumrine PK. The ketogenic diet in refractory epilepsy: the experience of Children's Hospital of Pittsburgh. Clin Pediatr 2000 [cited 2020 march 31];39(3):153-159. https://doi.org/10.1177/000992280003900303

Barwick K, Parker T, Murphy N, Todd A, Leveritt M, Wilkinson SA. Development and pilot testing of a parent-reported health-related quality of life measure for children on the ketogenic diet: The KetoQoL. Nutrition & Dietetics 2017 [cited 2020 march 31];74(5):521–528. https://doi.org/10.1111/1747-0080.12348

Poelzer K, Mannion C, Ortiz MM, Bang R, Woods P. A Systematic Review of the Quality of Life for Families Supporting a Child Consuming the Ketogenic Diet for Seizure Reduction. Curr Dev Nutr. 2018 [cited 2020 august 21]; 22(5): nzz079. https://doi.org/10.1093/cdn/nzy079

Luz IR, Pereira C, Garcia P, Ferreira F, Faria A, Macedo C et al. Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre. Acta Med Port. 2019 [cited 2020 august 21]; 32(12):760-766. https://doi.org/10.20344/amp.12184

Kverneland M, Molteberg E, Haavardsholm KC, Pedersen S, Ramm-Pettersen A, Nakken KO. Dietary therapy for epilepsy. Tidsskr Nor Laegeforen. 2017 [cited 2020 august 21];137(6). https://doi.org/10.4045/tidsskr.16.0486

Zhang Y, Wang Y, Zhou Y, Zhang L, Yu L, Zhou S. Therapeutic effects of the ketogenic diet in children with Lennox-Gastaut syndrome. Epilepsy Res. 2016 [cited 2020 august 21];128:176-180. https://doi.org/10.1016/j.eplepsyres

Ye F, Li XJ, Jiang WL, Sun HB, Liu J. Efficacy of and Patient Compilance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-Analysis. J Clin Neurol 2015 [cited 2020 jun 30];11(1):26-31. https://doi.org/10.3988/jcn.2015.11.1.26

McDonald TJW, Henry-Barron BJ, Felton EA, Gutierrez EG, Barnett J, Fisher R et al. Improving compliance in adults with epilepsy on a modified Atkins diet: A randomized trial. Europ J Epilepsy. 2018 [cited 2020 jun 30]; 60:132-8. https://doi.org/10.1016/j.seizure.2018.06.019

Publicado

2021-02-19

Como Citar

Lenycia de Cassya Lopes Neri, Vieira, R. R., Santana, S. M. M. de, & Sampaio, L. P. de B. (2021). Projeto piloto de implantação de uma cozinha cetogênica para tratamento de epilepsia refratária. REVISA, 10(1), 156–164. Recuperado de https://rdcsa.emnuvens.com.br/revista/article/view/492

Edição

Seção

Artigo Original